![David Searls](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Searls is Director of The ALS Therapy Development Institute.
Previously, he was senior Vice President of Bioinformatics at GlaxoSmithKline.
Previously, Dr. Searls was Faculty of the University of Pennsylvania.
Dr. Searls holds a PhD.
| Companies | Position | End |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ALS Therapy Development Foundation, Inc.
 ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
